Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-21

Clinical Trial Update: Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial [Phase 3]

View source ↗

Summary

Phase 3 trial of consensus interferon for treatment-naive hepatitis C genotype 1 completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infergen (interferon alfacon-1)

Snippet

Sponsor: Minneapolis Veterans Affairs Medical Center | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2014-11-21